08:00 , Feb 7, 2005 |  BioCentury  |  Emerging Company Profile

Cellectricon: Insights from inside

In many indications it is difficult to perform cell-based assays quickly and reproducibly. As a result, companies often have to rely on data derived from in vitro interactions. Cellectricon AB is developing chip-based consumables to...
08:00 , Dec 20, 2004 |  BC Week In Review  |  Company News

Sophion management update

Sophion Bioscience A/S , Copenhagen, Denmark   Business: Microfluidics, Supply/Service   Hired: Chris Mathes as VP and general manager for North America, previously manager of high throughput electrophysiology screening with Axon Instruments and Molecular Devices...
07:00 , Apr 19, 2004 |  BC Week In Review  |  Company News

Affymetrix, Axon Instruments Inc. deal

AXN received from AFFX rights to manufacture and sell scanners and software for conventional spotted microarrays. The deal does not apply to AFFX's GeneChip photolithographic microarray format, for which AFFX holds exclusive rights. Separately, AXN...
07:00 , Oct 13, 2003 |  BC Week In Review  |  Company News

Axon Instruments Inc., Cellectricon deal

AXN received an exclusive license to incorporate Cellectricon's electroporation technology into its Axoporator line of products used for inserting large molecules directly into single cells. Axon Instruments Inc. (ASX:AXN), Union City, Calif.   Cellectricon AB...
07:00 , Apr 14, 2003 |  BioCentury  |  Emerging Company Profile

Aviva: Celling chips

Aviva Biosciences Corp. hopes to ride the wave of laboratory automation by specializing in the manipulation of cells in labs-on-a-chip. The company identifies lab procedures that high throughput and automation have not yet reached and...
07:00 , Apr 14, 2003 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Aviva Biosciences Corp. San Diego, Calif. Technology: Cell manipulation and cell-based assays in biochips Disease focus: NA Clinical status: NA Founded: 1999 by Jing Cheng, Lei Wu and Julian Yuan Corporate partners: Axon Instruments Inc....
08:00 , Nov 25, 2002 |  BC Week In Review  |  Company News

Axon Instruments Inc. supply/service news

AXN reduced its headcount by 15% in order to focus on microarray genomics, neurosciences, fluorescence screening and ion channel screening. The company, which had $26 million in cash as of Oct. 31, said the move...
07:00 , Sep 30, 2002 |  BC Week In Review  |  Company News

Axon Instruments Inc., J&J deal

JNJ's Johnson & Johnson Pharmaceutical R&D LLC subsidiary will use AXN's PatchXpress 7000A high throughput ion channel patch clamp drug discovery technology. The product uses Patch-on-a-Chip planar electrodes from Aviva Biosciences Corp. (San Diego, Calif.)....
07:00 , Sep 23, 2002 |  BC Extra  |  Financial News

Aviva raises $11.8 million

Biochip developer Aviva Biosciences (San Diego, Calif.) raised $11.8 million in a first closing of its series B round led by China Development Industrial Bank. Other investors included Axon Instruments (ASX:AXN) and Pac-Link Management....
07:00 , Jun 17, 2002 |  BC Week In Review  |  Company News

Aviva, Axon Instruments Inc. deal

Aviva granted AXN exclusive marketing rights to its patch-clamp biochip. The companies also partnered to develop and commercialize a Patch-on-a-Chip planar electrode device for use in Axon's PatchXpress ion channel screening systems. PatchXpress is used...